- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02544516
Upside Down, Give me the Handle
November 21, 2016 updated by: Centre Hospitalier Universitaire de Saint Etienne
Study on the Links Between Perception and Action in Schizophrenia, "Upside Down, Give me the Handle"
In schizophrenia, dislocation of psychic functions involving a loss of contact with reality is frequently found.
A fragmentation of motor and sensory perceptions could be held responsible (Fuchs, 2005).
However, automatic integration between perception and action is the necessary condition to be in "relationship with the world."
Affordance is the experimental link between object perception and actions potentially associated (Gibson (1977, 1979) explored by Stimulus Response Compatibility (SRC) paradigm.
The existence of visual motor neurons leads us to postulate that the affordance effect can be assisted by a visuomotor priming of a hand in a position to grasp.
With Tucker & Ellis sensory motor compatibility task, we study the capacity of affordance in schizophrenia, as well as the impact of perceptual motor priming on these affordance effects.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All participants will perform cognitive tasks: reaction time (Alert TEA, Zimmermann and Fimm, 2005), Edinburgh laterality questionnaire (Oldfield, 1971), IQ test (IQ: PM38, Raven, 1960), and the PANSS (Positive and Negative Syndrome Scale, Kay et al., 1987).
Controls will only have the first three tasks (cognitive spots Alert and laterality).
Then all will perform all tasks in successive order (task 1 and task 2).
For both tasks, photographs of 20 objects of everyday life typical grip with one hand are presented in 4 orientations.
The instruction is to say if the object is presented upright or inverted; The second task differs from the first only by the introduction of a prime: presenting a hand in position "catching" before the picture of an object
Study Type
Interventional
Enrollment (Actual)
60
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint-etienne, France, 42000
- CHU de SAINT-ETIENNE
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years to 48 years (Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
For patients:
- a DSM-IV diagnosis of schizophrenia (men or women),
- no change in antipsychotic medication and clinical status within four weeks prior to the study
Exclusion Criteria:
- IQ < 70
For patients and control group Inclusion criteria
- Age ≥ 18 years et ≤ 50 years
Exclusion Criteria:
- History of head trauma,
- neurological disease with cerebral repercussion or not stabilized serious physical illness;
- psychotropic medication,
- disorders related to the use of a psychoactive substance (abuse, dependence or withdrawal);
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Patients
patients suffering schizophrenic disorders and who will perform cognitive tasks + PANSS+ IQ
|
Patients will have cognitive tasks: reaction time (Alert TEA, Zimmermann and Fimm, 2005), Edinburgh laterality questionnaire (Oldfield, 1971), IQ test (IQ: PM38, Raven, 1960), and the PANSS (Positive and Negative Syndrome Scale, Kay et al., 1987
|
Active Comparator: control group
healthy patients who will perform cognitive tasks
|
Patients will have cognitive tasks: reaction time (Alert TEA, Zimmermann and Fimm, 2005), Edinburgh laterality questionnaire (Oldfield, 1971),
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
response time
Time Frame: day 1
|
The gain provided by the compatible vs incompatible conditions (ms response time)
|
day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Catherine MASSOUBRE, MD, CHU de SAINT-ETIENNE
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
April 1, 2014
Primary Completion (Actual)
October 1, 2016
Study Completion (Actual)
October 1, 2016
Study Registration Dates
First Submitted
September 7, 2015
First Submitted That Met QC Criteria
September 7, 2015
First Posted (Estimate)
September 9, 2015
Study Record Updates
Last Update Posted (Estimate)
November 22, 2016
Last Update Submitted That Met QC Criteria
November 21, 2016
Last Verified
November 1, 2016
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1308139
- 2013-A01294-41 (Other Identifier: ANSM)
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Schizophrenic Disorders
-
AstraZenecaCompletedSchizophrenic DisorderBulgaria, Russian Federation, Romania, South Africa, Greece, Philippines, India, Indonesia
-
Shanghai Mental Health CenterStanley Medical Research InstituteWithdrawnCognitive Impairment | Schizophrenic DisorderChina
-
Shalvata Mental Health CenterBar-Ilan University, IsraelUnknownSchizophrenic PatientsIsrael
-
JanuelUnknownThe Impact of Stigma on the Quality of Life of People With Schizophrenic Disorders and Their Siblings
-
University Hospital, CaenCompletedAuditory Hallucinations in Patients With Schizophrenic DisordersFrance
-
US Department of Veterans AffairsCompletedSchizophrenia | Schizophrenic DisorderUnited States
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Eli Lilly and CompanyCompletedSchizophrenic DisordersTurkey, Finland
-
University Hospital, ToursRecruiting
-
Denovo Biopharma LLCCompletedSchizophrenic DisordersUnited States
Clinical Trials on cognitive tasks + PANSS+ IQ
-
Centre Hospitalier Universitaire de Saint EtienneCompleted
-
Centre Hospitalier Universitaire de Saint EtienneCompletedBipolar Affective DisorderFrance
-
University of California, Los AngelesDanone Nutricia ResearchCompleted
-
Nantes University HospitalCompleted
-
University Hospital, GrenobleCommissariat A L'energie Atomique; Laboratoire de Psychologie et NeuroCognitionCompleted
-
Universidade Federal do Rio Grande do NorteConselho Nacional de Desenvolvimento Científico e TecnológicoCompleted
-
University Hospital, GrenobleGrenoble Institut des NeurosciencesRecruitingCognition | Focal Brain InjuryFrance
-
University of VigoRecruiting
-
susanne beckerSNSFCompletedLow Back Pain | Pain, Acute | Pain, ChronicSwitzerland